Observia
Observia is a French digital health company that builds patient engagement and behavioral diagnostic solutions — most notably the SPUR™ adherence tool and OPC™ platform — for pharmaceutical companies, healthcare providers, insurers, and clinical trial sponsors across 25+ countries.
- Company typePrivate
- Founded2011
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Observia does
Observia is a French digital health company founded in 2011 and headquartered in Puteaux (La Défense), France. It develops patient engagement and behavioral diagnostic solutions sold primarily to pharmaceutical manufacturers (including Bayer, Novartis, and Sanofi), healthcare providers, insurers, payers, and pharmacy networks. The company reports a footprint of 100+ active clients, 80+ e-health solutions, 25+ countries, and 120 health specialties, with 50,000+ patients assessed by SPUR and 30,000 active patients across its platforms. The company holds 101–250 employees and operates under GDPR and HIPAA compliance frameworks.
The product portfolio rests on three core technologies: SPUR™, a behavioral diagnostic tool that measures drivers of patient non-adherence on a 0–100 scoring framework and is documented across 27 therapeutic areas and 7+ peer-reviewed publications; OPC™ (Observia Patient Cloud), the platform hosting 80+ e-health modules covering patient education, remote monitoring, and tele-consultation; and d.tells™, an AI-driven personalization and recommendation engine built on top of SPUR data. Adjacent offerings include SPUR4Care (prescriber-focused variant) and co-developed branded engagement programs such as "solike" with Bayer Germany.
The business model is B2B enterprise SaaS, monetized through licensed deployments of SPUR, OPC program subscriptions, and joint patient engagement programs co-built with pharma brand teams. Distribution is reinforced by a long-standing licensing arrangement with Mapi Research Trust and more recent clinical trial partnerships with Clinical Ink and Sciensus, which embed the platform into research and care-delivery workflows rather than competing as a standalone tool. The company has extended its physical footprint with a Shanghai subsidiary and Germany team established in 2018.
Observia firmographics
Firmographics- Name
- Observia
- Legal name
- Observia SAS
- Website
- https://observia-group.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Observia is a French digital health company that builds patient engagement and behavioral diagnostic solutions — most notably the SPUR™ adherence tool and OPC™ platform — for pharmaceutical companies, healthcare providers, insurers, and clinical trial sponsors across 25+ countries.
- Ownership category
- akta.pro rank
Observia industry classification
Industry- Product category
- Digital Health / Patient Engagement Software
- NAICS
- Custom Computer Programming Services (541511), Offices of Physicians (6211)
- SIC
- Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
Keywords
Where Observia is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Observia business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Enterprise Software Licenses and Subscriptions: Observia provides its SPUR tool and OPC platform to pharmaceutical companies, healthcare providers, and CROs through enterprise agreements. The company offers configurable solutions that pharmaceutical companies deploy for patient support programs, clinical trials, and market research.
- Consulting Services: Over 100 consulting projects including patient journey mapping, behavioral science consulting, and implementation support for pharma companies seeking to improve patient engagement and adherence.
- Platform Licensing: Licensing of OPC platform modules and d.tells personalization engine to pharmaceutical companies and healthcare organizations for building customized patient engagement solutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise B2B contracts for pharmaceutical companies and healthcare organizations |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Observia product offering
Product offeringCore offering
Observia develops and licenses a behavioral-science-driven patient engagement software suite for healthcare organizations. Its core offerings are SPUR™, a validated behavioral diagnostic tool that scores non-adherence risk and profiles patients across four dimensions and 13 drivers; OPC™ (Observia Patient Cloud), a modular platform with 40+ configurable e-health modules for omnichannel patient support programs; and d.tells™, an AI personalization engine that maps patient behavioral profiles to optimal content, channels, and timing. The company complements this software with professional consulting services for patient journey mapping, behavioral science integration, and program implementation.
Product overview
Observia offers a modular e-health platform architecture centered around three core products: OPC (Observia Patient Cloud) as the foundational digital platform with over 40 configurable modules; SPUR, a validated behavioral diagnostic tool generating 18 data points per patient including non-adherence risk scores and behavioral profiles across 4 dimensions and 13 drivers; and d.tells, an AI-powered personalization engine that matches patient behavioral data to optimal engagement configurations. The portfolio includes specialized solutions for pharmaceutical companies, healthcare professionals (SPUR4Care), pharmacists, and patients, with products addressing specific conditions such as multiple myeloma (HéMaVie), diabetes (Inodiab), and patient-caregiver matching (solike). The platform supports omnichannel delivery via email, SMS, chatbots, apps, and call centers, and is grounded in behavioral science methodologies.
Differentiator
Problem solved
Functional benefit
Brands
- SPUR™: First verified behavioral diagnostic tool that measures medication non-adherence risk and identifies behavioral drivers across 4 dimensions (Social, Psychological, Usage, Rational) with 13 underlying factors.
- OPC™ (Observia Patient Cloud)
- d.tells™
- My VKA Notebook
- solike
- HéMaVie™
- CaliPso
- L'Arbre Conseil®
- OSyS
Products and services
- SPUR™ Validated behavioral diagnostic tool that generates 18 data points per patient including a non-adherence risk score on a 0-100 scale, a holistic behavioral profile across four dimensions (Social, Psychological, Usage, Rational), and 13 behavioral drivers. Used by 50,000+ patients across 27 therapeutic areas with a 90% completion rate and under 3 minutes to complete.
- OPC™ (Observia Patient Cloud) Adaptable digital platform with a library of over 40 configurable e-health features for creating patient services and support programs. Supports multiple user types, devices, and channels (email, SMS, chatbots, apps, call centers), GDPR- and HIPAA-compliant, deployable across 13+ countries in 12+ languages.
- d.tells™ AI-powered personalization engine that creates personalized engagement plans by matching SPUR-derived patient behavioral profiles with optimal content, channels, timing, frequency, and tone. Automates selection and distribution of OPC platform features across multiple delivery channels.
- SPUR4Care Version of SPUR designed specifically for healthcare professionals (prescribers) to collect objective behavioral data during patient consultations to support clinical practice.
- Pharmacist Platform Platform dedicated to supporting community pharmacists in France with pharmaceutical interviews and shared medication reviews for chronic patients. Used by 4,000+ registered pharmacists with 12,000+ pharmaceutical interviews completed since 2013.
- solike First-of-its-kind patient and caregiver matching platform launched in partnership with Bayer Germany in 2023, designed to connect patients with their caregivers.
- My VKA Notebook Mobile application co-created with University of Angers for patients on anti-vitamin K anticoagulants, enabling monitoring of test results (INR), treatment reminders, appointment logging, and medication dosing information. Awarded Prix Galien 2017.
- L'Arbre Conseils® Mal de Tête Digital support tool co-created with Sanofi for pharmacists providing counseling advice to patients suffering from headaches at the pharmacy counter. Awarded Prix Galien 2023.
- HéMaVie™ Innovative digital support solution for patients suffering from multiple myeloma, providing comprehensive patient engagement features through the OPC platform.
- Inodiab SMS-based personalized program for improving Type 2 diabetes patient adherence through tailored SMS interventions delivered via community pharmacists.
- CaliPso Digital solution supporting daily management of psoriasis by patients, leveraging OPC modular features for ongoing engagement.
- OSyS First digital platform for first-recourse orientation at the pharmacy, helping pharmacists triage and direct patients to appropriate care.
- Observia Consulting Services Professional consulting services including patient journey mapping, behavioral science consulting, and implementation support for pharmaceutical and healthcare clients seeking to improve patient engagement and adherence. Over 100 consulting projects delivered.
Quantifiable outcome
- Treatment adherence in Type 2 diabetes patients increased from 60% to 87% over 6 months
- +5 more outcomes
Companies that use Observia
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles4 records
Observia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Observia partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Kingston UniversitycoreCollaborated with Kingston University to develop SPUR 6/24 patient-reported outcome tool. Joint research analyzed data from over 1,800 patients across three countries to identify psychological and social factors influencing medication non-adherence in chronic conditions.
- Clinical InkcoreStrategic partnership to expand patient engagement solutions using SPUR behavioral diagnostic tool in clinical trials. Combines Clinical Ink's eClinical platform with Observia's behavioral insights.
- SciensuscoreStrategic partnership to strengthen clinical trial offerings by integrating behavioral science into patient solutions through Sciensus's existing patient support programs.
- Mapi Research TrustcoreDistribution partnership for SPUR tool among research community. Mapi Research Trust distributes SPUR to academic and clinical researchers worldwide.
- Prevention JourneysminorPartnership to improve dementia prevention through behavioral science integration and patient engagement programs.
- BayercoreLaunched solike platform in Germany - a patient-caregiver matching service. Also partnered on menopause patient journey studies using SPUR and photo-elicitation methodologies.
- SanoficoreCo-created My VKA Notebook app (Prix Galien 2017) for patients on anti-vitamin K medication, and L'Arbre Conseils Mal de Tête solution (Prix Galien 2023) for pharmacist counseling.
- XPERTymecoreEurostars-funded agentic AI project to address patient adherence. Joint development of AI-powered patient engagement solutions.
- UNFPAminorIntegration of behavioral science into UNFPA programs with Kevin Dolgin and Anthony Daly, exploring behavioral science applications in public health contexts.
Scale indicators16 records
Recent moves10 records
Expansion highlights6 records
Observia competitors and assessment
Company assessmentDirect peers
- Click Therapeutics: Prescription digital therapeutics company combining behavioral science with software for chronic and mental health conditions. Comparable in its marriage of validated behavioral models and engagement platforms.
- Optimize Health: Patient engagement and chronic care management platform with omnichannel outreach (SMS, email, app). Comparable architecture to OPC, though more provider-centric than pharma-centric.
- Aptar Digital Health (formerly Voluntis): Pharma-facing digital health company offering patient engagement and adherence solutions (e.g., Insulia), with a comparable therapeutic-area focus and pharma co-development model that closely overlaps with Observia's SPUR + OPC + d.tells stack.
- Medisafe: Medication adherence and patient engagement platform with a personalized digital companion model. Directly comparable to Observia's OPC platform in the chronic-disease adherence category.
- S3 Connected Health: Pharma- and medtech-focused digital patient engagement and adherence platform with multi-year enterprise contracts. Highly comparable business model and customer base to Observia.
- Welldoc: Digital health company focused on chronic disease management with AI-driven personalization (similar to d.tells) and pharma/payer enterprise contracts, overlapping with Observia's therapeutic-area coverage.
- Adherium: Respiratory and chronic-disease adherence technology company with validated clinical evidence. Comparable in focusing on adherence outcomes and pharma partnerships.
Emerging players
- Kaia Health: Digital therapeutics for musculoskeletal and chronic pain, leveraging behavioral science and personalized engagement. Comparable to Observia's therapeutic-area + behavioral science orientation but more consumer-payer channel.
Broad incumbents
- Biofourmis: Larger virtual care and remote patient monitoring platform with pharma partnerships and AI-driven personalization, overlapping with Observia's chronic-disease patient engagement ambitions.
- Twill (formerly Happify Health): Digital health engagement platform combining behavioral science with enterprise pharma/health plan distribution, conceptually aligned with Observia's behavioral-engagement-for-pharma model at a larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Observia social profiles
Digital presenceObservia compliance and trust
Trust signalCompliance2 records
Observia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Observia leadership team
Management profileNumber of profiles
Profiles5 records
Observia subsidiaries and ownership
Company hierarchySubsidiaries1 record
Observia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Observia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Observia
What does Observia do?
Observia develops and licenses a behavioral-science-driven patient engagement software suite for healthcare organizations. Its core offerings are SPUR™, a validated behavioral diagnostic tool that scores non-adherence risk and profiles patients across four dimensions and 13 drivers; OPC™ (Observia Patient Cloud), a modular platform with 40+ configurable e-health modules for omnichannel patient support programs; and d.tells™, an AI personalization engine that maps patient behavioral profiles to optimal content, channels, and timing. The company complements this software with professional consulting services for patient journey mapping, behavioral science integration, and program implementation.
Is Observia a public or private company?
Observia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Observia founded?
Observia was founded in 2011. It employs 101 to 250 people.
Where is Observia based?
Observia is headquartered in Paris, France, in the Europe region.
How does Observia make money?
Three revenue lines are on record. Enterprise Software Licenses and Subscriptions are the primary driver. The others are consulting Services and platform Licensing.
Who are Observia's main competitors?
Direct peers on record are Click Therapeutics, Optimize Health, Aptar Digital Health (formerly Voluntis), Medisafe, S3 Connected Health, Welldoc and Adherium. Kaia Health is listed as an emerging player. Broad incumbents are Biofourmis and Twill (formerly Happify Health).
Does Observia have an API?
No public API is recorded for Observia.
What industry is Observia in?
Observia's product category is Digital Health / Patient Engagement Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 541511 and its SIC code is 7372.